Annual Financial Assessment
The European Medicine Agency (EMA) has established ‘eligibility criteria’ in order to make sure that it only establishes dialogues with the most suitable organisations that act in the interests of European patients, consumers and healthcare professionals. The European Association of Urology would like to engage in dialogue with the EMA and has provided the following information for the evaluation of eligibility.
As part of the evaluation for eligibility, the European Association of Urology has provided the following financial information (2019) to be assessed by the parameters as set by the European Medicine Agency:
- Royalties EAU scientific journal: 8.33% – 50% non-industry – 50% industry
- Membership fees 8.21% – 100% non-industry
- Registration fees 42.36% – 100% non-industry
- Results EAU meeting & education 40.22% – 100% industry
- Accounting and management consulting 0.59% – 100% non-industry
- Sold guidelines 0.22% – 100% non-industry
- Other income 0.06% – 100% non-industry
|Overall proportion of industry and non-industry:||44.79% vs 55.21%|
The following pharmaceutical companies provide funding to EAU:
- IPSEN innovation
- Janssen Pharmaceutical N.V.
- Karl Storz SE & Co. KG
- Olympus Europa SE & CO. KG
- Intuitive Surgical Sarl
- Astellas Pharma
- Bristol-Myers Squibb
- Boston Scientific
- Cook Medical Europe Ltd.
The highest contribution from a single company is less than 3% of the organisation’s total income. The financial Annual Report of 2019 by the EAU can be found here: Compilation Report 2019.
Geographic Spread of EAU Membership
Code of Ethics
In order to ensure good governance, interactions should be based on fundamental principles of integrity, mutual respect, responsiveness, accountability, collaboration and transparency. The EAU Code of Ethics set standards for industry partners with regard to ethical interactions with the healthcare community. In order to make funding partnerships work in practice, to ensure the integrity of both the funder and EAU is maintained, and to demonstrate to other stakeholders that our relationships are absolutely scrupulous, the following key principles underpin our acceptance of funding.
Public Engagement Highlights 2018
EMA’s Public Engagement Department was set up to facilitate the involvement of patients, consumers, healthcare professionals (HCPs) and academics in the work of the Agency. Their highlights for 2018 can be found here: